Enveric Biosciences, Inc. (ENVB) Tops Q3 EPS by 28c

Enveric Biosciences, Inc. (NASDAQ: ENVB) reported Q3 EPS of ($0.24), $0.28 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Enveric Biosciences, Inc. (ENVB) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
• S&P 500 may pull back before midterms, but Citi says buy the dip